Know Cancer

or
forgot password

Outcomes of Cutaneous T-Cell Lymphoma and Chronic Graft-Versus-Host Disease in Patients Treated With Extracorporeal Photopheresis


N/A
18 Years
N/A
Open (Enrolling)
Both
Cutaneous T Cell Lymphoma, Graft Versus Host Disease

Thank you

Trial Information

Outcomes of Cutaneous T-Cell Lymphoma and Chronic Graft-Versus-Host Disease in Patients Treated With Extracorporeal Photopheresis


The investigators intend to report outcomes from the inception of this procedure at
Dartmouth-Hitchcock Medical Center (DHMC) in May 2008 through 9/30/11. Additionally, the
investigators would like to maintain a prospective database of these patients so that new
patient data can be collected for updating of outcomes.


Inclusion Criteria:



- Patients who receive Extracorporeal Photopheresis treatment

- Treated at Dartmouth-Hitchcock Medical Center

- Must be 18 years or older

Type of Study:

Observational

Study Design:

Observational Model: Case-Only, Time Perspective: Prospective

Outcome Measure:

Response rates

Outcome Description:

Response rates to ECP treatment

Outcome Time Frame:

1 year

Safety Issue:

No

Principal Investigator

Frederick Lansigan, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Dartmouth-Hitchcock Medical Center

Authority:

United States: Institutional Review Board

Study ID:

D11271

NCT ID:

NCT01460914

Start Date:

October 2011

Completion Date:

October 2050

Related Keywords:

  • Cutaneous T Cell Lymphoma
  • Graft Versus Host Disease
  • ECP
  • CTCL
  • Extracorporeal photopheresis
  • Cutaneous T Cell Lymphoma
  • GVHD
  • Graft versus host disease
  • Graft vs Host Disease
  • Lymphoma
  • Lymphoma, T-Cell
  • Lymphoma, T-Cell, Cutaneous

Name

Location

Dartmouth-Hitchcock Medical CenterLebanon, New Hampshire  03756